Hexima puts up its defensins

By Dylan Bushell-Embling
Thursday, 31 July, 2008

Agbiotech company Hexima [ASX: HXL] has concluded a set of trials of its defensin-based technology in cotton crops.

The trials tested the company's genetically modified strains against two common fungal diseases, verticillium wilt and fusarium wilt.

Both crops demonstrated increased yield, and the modified plants in the fusarium trial showed increased survival rates.

A third, healthy, crop was also modified with defensin to test the effect of the technology on healthy plants. The crop showed no adverse effects.

Defensins are small peptides, analogues of which are also found in humans and other animals, which help destroy bacteria and fungi. Some are also thought to have insecticidal activity.

Related News

Quitting smoking increases life expectancy even for seniors

Although the benefits of quitting smoking diminish with age, there are still substantial gains...

Stem cell transplants treat blindness in mini pigs

Scientists have successfully transplanted retinas made from stem cells into blind mini pigs,...

Sugary drinks raise cardiovascular disease risk, but occasional sweets don't

Although higher sugar intake raises your risk of certain cardiovascular diseases, consuming sweet...


  • All content Copyright © 2025 Westwick-Farrow Pty Ltd